Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
19.88 USD | -0.45% | -3.21% | -7.66% |
May. 22 | Cancer victims sue Johnson & Johnson over 'fraudulent' bankruptcies | RE |
May. 20 | Goldman Sachs Adjusts Kenvue Price Target to $21 From $20 | MT |
Financials (USD)
Sales 2024 * | 15.69B | Sales 2025 * | 16.23B | Capitalization | 38.07B |
---|---|---|---|---|---|
Net income 2024 * | 1.71B | Net income 2025 * | 2.08B | EV / Sales 2024 * | 2.87 x |
Net Debt 2024 * | 6.93B | Net Debt 2025 * | 6.41B | EV / Sales 2025 * | 2.74 x |
P/E ratio 2024 * |
21.9
x | P/E ratio 2025 * |
18.3
x | Employees | 22,000 |
Yield 2024 * |
3.85% | Yield 2025 * |
4.14% | Free-Float | 99.72% |
Latest transcript on Kenvue Inc.
1 day | -0.45% | ||
1 week | -3.21% | ||
Current month | +5.63% | ||
1 month | +1.53% | ||
3 months | +3.60% | ||
6 months | -0.80% | ||
Current year | -7.66% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 34 M€ | +13.78% | - | |
0.07% | 26 M€ | +16.85% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-22 | 19.88 | -0.45% | 15,202,580 |
24-05-21 | 19.97 | +0.35% | 27,778,988 |
24-05-20 | 19.9 | -2.78% | 24,636,833 |
24-05-17 | 20.47 | -0.63% | 31,071,005 |
24-05-16 | 20.6 | +0.29% | 71,519,401 |
Delayed Quote Nyse, May 22, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.66% | 38.07B | |
+14.51% | 396B | |
+13.42% | 136B | |
+18.88% | 77.74B | |
-10.88% | 66.79B | |
-10.58% | 46.89B | |
+8.18% | 35.65B | |
+11.08% | 18.19B | |
+16.15% | 16.04B | |
+0.75% | 11.79B |
- Stock Market
- Equities
- KVUE Stock